Doxycycline-mediated inhibition of choroidal neovascularization.
about
Ocular drug delivery.Doxycycline's effect on ocular angiogenesis: an in vivo analysis.The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularizationOcular penetration of topically applied 1% tigecycline in a rabbit model.A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.Systemic low-molecular weight drug delivery to pre-selected neuronal regionsIL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularizationOcular surface immunity: homeostatic mechanisms and their disruption in dry eye diseaseDifferential Effects of Dexamethasone and Doxycycline on Inflammation and MMP Production in Murine Alkali-Burned Corneas Associated with Dry Eye.The effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialMatrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.Anti-inflammatory and Anti-apoptotic Effect of Valproic Acid and Doxycycline Independent from MMP Inhibition in Early Radiation Damage.All vessels are not created equal.Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration.Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage
P2860
Q30475605-9ECEA8F6-FFED-420C-A41D-A9DA86CE25F3Q33626160-DCA86F5C-F0E4-48BE-BDCE-B56AD788D74DQ33677016-F1A78039-D1E1-47DD-9CAF-D0D7343E16E6Q33706051-61DDBE06-7FDE-48EA-9427-3B743419B6FCQ33811616-A956BB04-E54C-4093-9D7C-FD233E8AB9C6Q33837170-D0C27A91-1CA1-4717-B808-53770B16F57DQ34064081-2AC49754-8DFC-4881-8888-6152BD2A51B0Q34277464-69662416-7C2A-4D7B-B61E-E915262DE51BQ35087983-9B359096-CA1B-410F-8BE3-E3F308702599Q35907009-209CE5B4-A3F9-4D51-A9E5-43174491C858Q36829083-A79BA944-3ACC-42A0-95C9-A066C0CB7F61Q37000498-0A653391-1A0C-4BDB-8FB8-530402A2F0F0Q37242419-8C20E0CF-F92A-42EC-8BCF-1CA6AEF6EF4AQ41383708-6124B976-FDDB-4799-8E18-80101D017F0FQ47179466-D052CB3C-31B3-48C2-9FEB-82EA6C46A402Q48524275-ED03A707-F9F7-4510-96F3-079F7FC8371BQ58799509-EB0DB8E4-8D59-4575-953A-4AE34B5412B4
P2860
Doxycycline-mediated inhibition of choroidal neovascularization.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Doxycycline-mediated inhibition of choroidal neovascularization.
@ast
Doxycycline-mediated inhibition of choroidal neovascularization.
@en
type
label
Doxycycline-mediated inhibition of choroidal neovascularization.
@ast
Doxycycline-mediated inhibition of choroidal neovascularization.
@en
prefLabel
Doxycycline-mediated inhibition of choroidal neovascularization.
@ast
Doxycycline-mediated inhibition of choroidal neovascularization.
@en
P2093
P2860
P356
P1476
Doxycycline-mediated inhibition of choroidal neovascularization.
@en
P2093
Maria M Campos
S Patricia Becerra
Sonia Samtani
P2860
P304
P356
10.1167/IOVS.08-3174
P407
P577
2009-06-10T00:00:00Z